Ametek acquires Indicor’s instrumentation units for $5bn
▼ Summary
– Clayton, Dubilier & Rice is selling a test-and-measurement subset of its Indicor portfolio to Ametek for $5bn, marking a large partial exit from a 2022 Roper Technologies carve-out.
– The deal gives Ametek picks-and-shovels exposure to AI infrastructure, as Indicor’s test-and-measurement equipment serves semiconductor, pharma, aerospace, and energy customers.
– CD&R acquired the entire Indicor portfolio at a $3.6bn enterprise value in 2022, and the partial sale implies a 12-14x EBITDA multiple, with a projected 2.5-3.5x money multiple on original equity.
– Roper, which retained a 49% minority stake in Indicor, will receive a proportional share of the $5bn proceeds, validating its shift to higher-multiple software operations.
– The remaining pumps-and-valves businesses within Indicor will stay under CD&R ownership for a future separate exit, while Ametek’s combined revenue will approach $9bn.
Ametek, the Pennsylvania-based manufacturer of scientific and industrial instrumentation, has struck a deal to acquire the test-and-measurement division of Indicor for roughly $5 billion. This transaction marks the largest single partial exit for Clayton, Dubilier & Rice in 2026, coming just three and a half years after the private equity firm carved the portfolio out of Roper Technologies. The Wall Street Journal first reported exclusive negotiations in late April, and the final agreement represents a clean, high-multiple exit in a challenging mid-market industrial environment.
Indicor was formed in 2022 when CD&R took a 51 percent majority stake at a $3.6 billion enterprise value, while Roper retained a 49 percent minority interest and received $2.6 billion in upfront cash. The portfolio, which adopted the Indicor name in January 2023, brought together 16 industrial instrumentation brands,including Alpha, AMOT, CCC, Cornell, Dynisco, Roper Pump, Struers, and Uson,with combined 2022 revenue of approximately $1.1 billion across pumps, valves, test-and-measurement equipment, sensors, and meters.
Ametek is not acquiring the entire Indicor portfolio. The deal focuses specifically on the test-and-measurement assets, leaving the pumps-and-valves businesses,Roper Pump, Cornell, AMOT, and Hansen,inside Indicor under CD&R’s continued majority ownership. Per confirmation from Private Equity Wire, these assets align precisely with Ametek’s core instrumentation expertise: precision measurement, materials testing, polymer-process analytics, and process-control sensors. Ametek has spent two decades rolling up such categories through bolt-on acquisitions.
On disclosed financials, CD&R is selling roughly half the Indicor portfolio for $5 billion after acquiring the entire portfolio at a $3.6 billion enterprise value four years ago. Private Equity Insights’ deal analysis places the implied multiple in the 12-14x EBITDA range, and the firm is on track for a 2.5–3.5x money multiple on its original equity once the remaining pumps-and-valves businesses exit separately. By current mid-market industrial-buyout standards, that performance is exceptional. The 2025-early 2026 period has been visibly difficult for PE industrial exits, with rising rates and compressed strategic-buyer multiples making clean exits hard to clear.
Roper, the original seller, also benefits. Per its 2022 announcement, its 49 percent minority interest entitles it to a proportional share of exit proceeds. Wednesday’s transaction returns material cash to Roper on top of the original $2.6 billion, providing useful side validation of its decision to divest the industrial businesses in favor of higher-multiple software operations.
Most strategic M&A coverage in 2026 has revolved around AI infrastructure and frontier-model distribution. TNW reported this week on Blackstone-KKR-Google AI tie-up talks, Blackstone’s $1.75 billion data-centre REIT IPO, the Anthropic services firm launch, and OpenAI’s $10 billion DeployCo close. The Ametek-Indicor deal is none of those, but its underlying customer base,semiconductor manufacturers, pharmaceutical producers, aerospace-and-defence integrators, and energy-sector operators,is exactly the cohort the AI build-out is feeding through the supply chain.
In this frame, Ametek represents one of the cleaner picks-and-shovels public-market positions in the AI-infrastructure trade, without ever describing itself in those terms. Samsung Electronics crossing $1 trillion on AI memory demand and STMicroelectronics’ $3 billion space-chip revenue target follow the same pattern. The instrumentation companies that test, measure, and validate the chips and process flows behind those numbers are beneficiaries of every part of the build-out simultaneously. The combined Ametek-plus-Indicor revenue base will approach $9 billion.
The deal is expected to close in the second half of 2026, subject to regulatory approval. CD&R will prepare the remaining pumps-and-valves businesses for a separate exit. Ametek will execute the integration in the same disciplined way it has executed its previous bolt-ons. None of this is glamorous. All of it, on the available evidence, compounds.
(Source: The Next Web)